| Literature DB >> 24955836 |
Elsa Mével1, Laurent-Emmanuel Monfoulet2, Christophe Merceron3, Véronique Coxam2, Yohann Wittrant2, Laurent Beck3, Jérôme Guicheux4.
Abstract
Osteoarthritis (OA) is a degenerative joint disease with no curative treatments. Many studies have begun to demonstrate the efficacy of nutraceuticals for slowing down OA. Animal models are utilized as a compulsory step in demonstrating the protective potential of these compounds on joint health. Nevertheless, there exist a wide variety of available OA models and selecting a suitable system for evaluating the effects of a specific compound remains difficult. Here, we discuss animal studies that have investigated nutraceutical effects on OA. In particular, we highlight the large spectrum of animal models that are currently accepted for examining the OA-related effects of nutraceuticals, giving recommendations for their use.Entities:
Mesh:
Year: 2014 PMID: 24955836 DOI: 10.1016/j.drudis.2014.06.012
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851